Skip to main content
SLAS2024 Main banner
Sartorius Ad
Back

Rob Howes, PhD (he/him/his)

Charles River, England, United Kingdom

Rob Howes PhD is currently Head of Discovery Science UK at Charles River joining recently from spending the last 3 years as part of the UK’s response to Covid-19 leading the Rosalind Franklin Laboratory. He worked previously AstraZeneca leading teams across early drug discovery providing biochemical and cellular reagents and assays with a focus on cardiovascular, metabolic and respiratory disease areas.
Rob started his industrial career at Vernalis, a UK biotech company focused on developing cancer therapeutics using structure-based drug design. In 2008 he joined Horizon Discovery, a UK biotech company developing the rAAV genome editing technology, as Research Director. He built several teams and labs in the UK and Italy and led collaborations with over 50 academic groups across the globe. He is deeply involved with the Society for Laboratory Automation and Screening (SLAS) where he serves on the editorial board of the SLAS Discovery journal, hosts the SLAS Discovery podcast and has advised and chaired at several conferences including SLAS annual conferences. At the end of 2020 he was nominated as a SLAS Fellow in recognition of his contributions to the Society. He is a Fellow of the Royal Society of Biology and a member of the ELRIG General Committee.

Disclosure information not submitted.

Presentation(s):